UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2020 | 2021-02-25 | Future report Set alerts | |
| Q3 2020 | 2020-11-09 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | 0.47 | -0.73 |
| Q1 2020 | 2020-05-11 | 0.47 | -2.79 |
| Q4 2019 | 2020-02-27 | 0.47 | 0.31 |
| Q3 2019 | 2019-11-12 | 0.40 | -0.32 |
| Q2 2019 | 2019-08-08 | 0.51 | -1.75 |
| Q1 2019 | 2019-05-09 | 0.59 | -1.36 |
| Q4 2018 | 2019-03-18 | 0.64 | -2.42 |
| Q3 2018 | 2018-11-07 | 0.54 | 1.62 |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-12 | Boost Price Target | Citigroup Inc. | Buy | $18.00 to $19.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Reiterated Rating | FBR & Co. | Buy | $21.50 |
| 2016-03-16 | Lower Price Target | Barclays | Equal Weight | $20.00 to $16.00 |
| 2016-03-16 | Lower Price Target | Barclays PLC | Equal Weight | $20.00 to $16.00 |
| 2015-05-22 | Reiterated Rating | JMP Securities | Outperform | $21.50 to $21.00 |
| 2015-05-13 | Reiterated Rating | JMP Securities | Outperform | $21.50 to $21.00 |
| 2014-11-14 | Lower Price Target | Citigroup Inc. | Buy | $22.00 to $21.00 |
| 2014-11-13 | Lower Price Target | Barclays | Overweight to Equal Weight | $24.00 to $20.00 |
| 2014-08-14 | Reiterated Rating | Citigroup Inc. | Buy | $21.00 to $22.00 |
| 2014-08-07 | Initiated Coverage | JMP Securities | Outperform | $21.50 |
| 2014-04-01 | Reiterated Rating | Morgan Stanley | Equal Weight | $20.00 to $21.00 |
| 2014-03-26 | Boost Price Target | Barclays | Overweight | $22.00 to $24.00 |
| 2013-10-30 | Initiated Coverage | Morgan Stanley | Overweight | |
| 2013-10-29 | Initiated Coverage | Sterne Agee CRT | Buy | |
| 2013-10-29 | Initiated Coverage | FBR & Co. | Outperform | $20.00 |
| 2013-10-29 | Initiated Coverage | Citigroup Inc. | Buy | |
| 2013-10-29 | Initiated Coverage | Barclays | Overweight | $22.00 |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-12 | Boost Price Target | Citigroup Inc. | Buy | $18.00 to $19.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Reiterated Rating | FBR & Co. | Buy | $21.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CHMI 75 funds of 2197 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 1.59M |
| RENAISSANCE TECHNOLOGIES LLC | 1.16M |
| Vanguard Group, Inc | 0.85M |
| STATE STREET CORP | 0.71M |
| MACKAY SHIELDS LLC | 0.26M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.23M |
| Winton Capital Group Ltd | 0.19M |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.19M |
| NORTHERN TRUST CORP | 0.18M |
| BlackRock Fund Advisors | 0.17M |
| Granite Point Capital Management, L.P. | 0.14M |
| PRUDENTIAL FINANCIAL INC | 0.13M |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.10M |
| CREDIT SUISSE AG/ | 74538 |
| Nuveen Asset Management, LLC | 72574 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Middleman Stanley C. | 13.32% (1000000) | CHMI / |
| KISLAK JONATHAN | 0.46% (34501) | CHMI / |
| Levine Martin Chief Financial Officer | 0.39% (29517) | CHMI / |
| Murin Joseph J | 0.18% (13233) | CHMI / |
| Lowrie Regina | 0.12% (9053) | CHMI / |
| Lown Jay Chief Investment Officer | 0.10% (7350) | CHMI / |
| Evans Julian Chief Investment Officer | 0.04% (3250) | CHMI / |
| Salcetti Robert A | 0.04% (3181) | CHMI / DX / OCN / |
| Mercer Robert C JR | 0.04% (2733) | CHMI / |
Undercovermarket.com